Tag
China's NMPA has begun reviewing Novo Nordisk's marketing application for Rybelsus tablet, marking a key regulatory milestone for the drug in the Chinese market.
A study finds that Semaglutide, a drug for diabetes and weight loss, is associated with a 26% lower predicted risk of dementia over a 5-year period.
Quantinuum and NVIDIA, with a pharmaceutical partner, validated a proof-of-principle Generative Quantum AI (GenQAI) framework that combines HPC, AI, and quantum computing to generate and execute quantum circuits for pharmaceutical R&D.
AI accelerates drug discovery by predicting candidates and reducing costs, but success depends on high-quality data and integration with lab systems to close the data loop and validate predictions.
o11, an AI agent for enterprise apps, launches specifically for the life sciences sector, targeting pharmaceutical and life science companies. The product is backed by prominent investors including Y Combinator, Accel, and OpenAI.
Amgen, a major pharmaceutical company, shares how it leverages GPT-5 in its operations. The case study highlights enterprise adoption of advanced AI models in the biotech/pharma sector.